Across the 11 outcomes, rates ranged from 0.2 per 1000 person‐years for gastroparesis in the SGLT2‐I cohort to 13.7 per 1000 person‐years for MI or stroke hospitalizations in the GLP‐1‐RA cohort (Table 2). This evidence concerns the gene SLC5A2 and gastroparesis.